Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder

Lilly

Status and phase: Completed; Phase 3

Conditions: Anxiety Disorders

Treatments: Drug: duloxetine hydrochloride; Drug: placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT00122824

F1J-MC-HMBR

5075

Details and patient eligibility

About

This is a clinical trial assessing duloxetine compared with placebo in patients who have generalized anxiety disorder.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female outpatients at least 18 years of age

Exclusion criteria

• Have previously completed or withdrawn from this study or any other study investigating duloxetine or have previously been treated with duloxetine
• Patient diagnosed with major depressive disorder within the past 6 months
• Patient diagnosed with panic disorder, post-traumatic stress disorder, or an eating disorder within the past year
• History of alcohol or any psychoactive substance abuse or dependence within the past 6 months

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind